Who
Jeffrey N. Simmons
President, CEO and Director
Company insider
Files Form 4 as: President, CEO and Director, Elanco Animal Health; SVP&Pres. Elanco Animal Health, Eli Lilly and; Director, Chiquita Brands International.
In numbers
- Trades disclosed
- 223
- Buys
- 9
- Sells
- 6
- Bought
- $5.6M
- Sold
- $5.0M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 26 Jan 2010
- Last trade
- 2 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 6 Oct 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827127.684 at $22.14 | filing |
| 18 Sep 2026filed 22 Sep 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827126.09 at $22.42 | filing |
| 18 Sep 2026filed 22 Sep 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827126.09 at $22.42 | filing |
| 4 Sep 2026filed 9 Sep 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827115.385 at $24.50 | filing |
| 4 Sep 2026filed 9 Sep 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827115.38 at $24.50 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827117.936 at $23.97 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827117.94 at $23.97 | filing |
| 7 Aug 2026filed 10 Aug 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827127.8 at $22.12 | filing |
| 7 Aug 2026filed 10 Aug 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827127.8 at $22.12 | filing |
| 24 Jul 2026filed 28 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827113.486 at $24.91 | filing |
| 24 Jul 2026filed 28 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827113.49 at $24.91 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827113.897 at $24.82 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827113.9 at $24.82 | filing |
| 26 Jun 2026filed 30 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827115.056 at $24.57 | filing |
| 26 Jun 2026filed 30 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827115.06 at $24.57 | filing |
| 12 Jun 2026filed 16 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827116.96 at $24.17 | filing |
| 12 Jun 2026filed 16 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827116.96 at $24.17 | filing |
| 29 May 2026filed 2 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827118.53 at $23.85 | filing |
| 29 May 2026filed 2 Jun 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,827118.53 at $23.85 | filing |
| 15 May 2026filed 19 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $100K4,971 at $20.09 | filing |
News
No headline names them, or the companies they trade most, lately.